ARX:ASX
Aroa Biosurgery Ltd
AU$0.48
0.00%
(0.00) 1D
ኖቬም 20, 4:10:06 ከሰዓት ጂ ኤም ቲ+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Mkt. cap
167.76 ሚ
Avg. vol.
261.76 ሺ
Volume
0.00
P/E ratio
45.75
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
Mkt. cap
167.76 ሚ
Avg. vol.
261.76 ሺ
Volume
0.00
P/E ratio
45.75
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
News stories
From web sources and news partners
AP News
·
ከ1 ቀን በፊት
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
The Motley Fool
·
ከ14 ሰዓቶች በፊት
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
24/7 Wall St.
·
ከ3 ሰዓቶች በፊት
Billionaire Ray Dalio's Bridgewater Keeps 16% of Its $23 Billion Stock Portfolio in S&P 500 Index Funds, Even After Cutting Them
Beinsure
·
ከ1 ቀን በፊት
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd